Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Genetic

Explore clinical trials studying Skin Diseases, Genetic. Study availability and eligibility vary by location and protocol.

1,834 public trials 277 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Genetic trial results

Completed

A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable

NCT02755649

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Site 1 Vienna, Austria
  • Site 2 Vienna, Austria
  • Brussels, Belgium
  • Leuven, Belgium
View all 73 locations
View Trial Details
Completed

A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

NCT03334396

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Kozni ambulance Kutna Hora, s.r.o. Kutná Hora, Central Bohemia, Czechia
  • Clintrial, s.r.o. Prague, Hl. M. Praha, Czechia
  • Fakultni nemocnice Kralovske Vinohrady Prague, Hl. M. Praha, Czechia
  • Fakultni Nemocnice v Motole Prague, Hl. M. Praha, Czechia
View all 93 locations
View Trial Details
Completed

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of California - San Diego San Diego, California, United States
  • National Jewish Health General Clinical Research Center Denver, Colorado, United States
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

NCT03345914

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Regeneron Research Site Birmingham, Alabama, United States
  • Regeneron Research Site Gilbert, Arizona, United States
  • Regeneron Research Site Bakersfield, California, United States
  • Regeneron Research Site Long Beach, California, United States
View all 61 locations
View Trial Details
Completed

A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

NCT03733301

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Centro de Investigaciones Metabólicas (CINME) - Comite Ciudad Autonoma Buenos Aires, Argentina
  • Fundacion CIDEA Ciudad Autonoma Buenos Aires, Argentina
  • Instituto de Neumonología y Dermatología Ciudad Autonoma Buenos Aires, Argentina
  • Psoriahue Medicina Interdisciplinaria Ciudad Autonoma Buenos Aires, Argentina
View all 68 locations
View Trial Details

Related conditions